TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Share-based Payments (Tables)

Share-based Payments (Tables)

3 Months Ended

Mar. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Warrants, Activity

The warrants expire March 18, 2015.

	2014				2013
			Weighted				Weighted
			Average				Average
	Warrants		Exercise Price		Warrants		Exercise Price

Outstanding at January 1		1,989	$	71.76		47,211	$	48.54
Cancelled during year		-		-		-		-
Expired during year		-		-		-		-
Outstanding at March 31		1,989	$	71.76		47,211	$	48.54

Schedule of Share-based Compensation, Stock Options, Activity

Qualified option holders may exercise their options at their discretion. Each option granted may be exchanged for a prescribed number of shares of common stock.

Employee's Plan	2014				2013
			Weighted				Weighted
			Average				Average
	Options		Exercise Price		Options		Exercise Price

Outstanding at January 1		-	$	-		1,579	$	42.12
Forfeited during year		-		-		-		-
Expired during year		-		-		-		-
Outstanding at March 31		-	$	-		1,579	$	42.12

Director's Plan	2014				2013
			Weighted				Weighted
			Average				Average
	Options		Exercise Price		Options		Exercise Price

Outstanding at January 1		-	$	-		352	$	312.00
Cancelled during year		-		-		-		-
Expired during year		-		-		-		-
Outstanding at March 31		-	$	-		352	$	312.00

Summary of Warrants and Stock Options Outstanding and Exercisable

A summary of warrants and stock options outstanding and exercisable as of March 31, 2014 follows:

							Outstanding				Excercisable
							Wgtd Avg		Wgtd Avg				Wtgt Avg
							Life		Exercise				Exercise
	Low		High		Shares		Remaining		Price		Shares		Price
Warrants	$	71.76	$	71.76		1,989		0.98	$	71.76		1,989	$	71.76